| Literature DB >> 34100197 |
Motofumi Kumazoe1, Yasutake Tanaka1, Ren Yoshitomi1, Yuki Marugame1, Kwan-Woo Lee1, Hiroaki Onda1, Yoshinori Fujimura1, Madoka Yonekura2, Yasuyo Shimamoto2, Hirofumi Tachibana3.
Abstract
Animal and clinical studies have revealed that (-)-epigallocatechin-3-O-gallate (EGCG), one of the major bioactive polyphenols in green tea, showed several pharmacological effects including anti-obesity effect and anti-inflammatory effect. We previously reported that the second messenger cyclic guanosine monophosphate (cGMP) mediates its anti-inflammatory and anti-cancer properties. Here we demonstrated that glucosyl-hesperidin, enhances the cGMP-inducing effects of green tea extract in vivo. Moreover, glucosyl-hesperidin intake potentiated the green tea-elicited upregulation of the anti-inflammatory factor, toll-interacting protein.Entities:
Keywords: Biomarker; Glucosyl-hesperidin; Green tea; cGMP
Year: 2021 PMID: 34100197 DOI: 10.1007/s11418-021-01538-6
Source DB: PubMed Journal: J Nat Med ISSN: 1340-3443 Impact factor: 2.343